It all depends on how you look at things. According to new data, the
number of new drugs approved by FDA in 2008 rose and was the highest it's been in three years. Not so fast, says blogger Merrill Goozner, who argues that numbers don't reflect what is really an
ongoing "innovation drought" in the pharma pipeline.
"